... in the stock and then a big loss in Amgen's (NASDAQ: AMGN ) suit against it for infringing Repatha's patents. TARRYTOWN, N.Y and PARIS, April 1, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. and Sanofi today announced that two ...
http://ift.tt/1MHAc78
No comments:
Post a Comment